Free Trial

Blend Labs (NYSE:BLND) Price Target Lowered to $5.00 at Wells Fargo & Company

Blend Labs logo with Computer and Technology background

Blend Labs (NYSE:BLND - Get Free Report) had its price objective lowered by equities research analysts at Wells Fargo & Company from $6.00 to $5.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an "overweight" rating on the stock. Wells Fargo & Company's price target suggests a potential upside of 65.02% from the company's previous close.

A number of other equities analysts have also weighed in on BLND. Keefe, Bruyette & Woods lowered their price target on shares of Blend Labs from $3.85 to $3.50 and set a "market perform" rating on the stock in a research report on Monday, March 3rd. UBS Group cut their target price on Blend Labs from $4.00 to $3.50 and set a "neutral" rating for the company in a research note on Friday, February 28th. Finally, Canaccord Genuity Group lowered their price target on shares of Blend Labs from $5.75 to $5.25 and set a "buy" rating on the stock in a research report on Friday, February 28th. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $4.70.

Get Our Latest Report on BLND

Blend Labs Price Performance

Shares of Blend Labs stock opened at $3.03 on Tuesday. The business has a 50 day simple moving average of $3.42 and a two-hundred day simple moving average of $3.91. The stock has a market capitalization of $786.78 million, a P/E ratio of -8.91 and a beta of 1.29. Blend Labs has a 12 month low of $2.08 and a 12 month high of $5.53.

Insider Buying and Selling at Blend Labs

In other Blend Labs news, insider Brian Kneafsey sold 30,000 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $3.73, for a total value of $111,900.00. Following the completion of the sale, the insider now owns 776,759 shares in the company, valued at approximately $2,897,311.07. The trade was a 3.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 13.21% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Blend Labs

A number of large investors have recently bought and sold shares of BLND. Merit Financial Group LLC purchased a new stake in shares of Blend Labs during the 1st quarter worth approximately $36,000. JPL Wealth Management LLC purchased a new stake in Blend Labs in the 4th quarter valued at approximately $42,000. Balyasny Asset Management L.P. purchased a new position in Blend Labs during the fourth quarter worth $46,000. Olympiad Research LP acquired a new position in shares of Blend Labs in the fourth quarter worth $47,000. Finally, Pallas Capital Advisors LLC acquired a new stake in shares of Blend Labs during the first quarter valued at $51,000. Hedge funds and other institutional investors own 52.56% of the company's stock.

Blend Labs Company Profile

(Get Free Report)

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.

See Also

Analyst Recommendations for Blend Labs (NYSE:BLND)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Blend Labs Right Now?

Before you consider Blend Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.

While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines